Insider Shareholders with Direct Ownership of Harpoon Therapeutics, Inc. (HARP)
This section provides a comprehensive overview of the insiders with direct ownership of Harpoon Therapeutics, Inc. (HARP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Harpoon Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
3,898,869 | 447 | 3,648,422 $0 | 2 |
Feb 12, 2019
Reduced 0.01%
|
|
Georgia Erbez
Chief Financial Officer |
25,000 | 0 | 72,292 $0 | 1 |
Feb 17, 2021
Added 25.7%
|
|
Holger Wesche
Chief Scientific Officer |
40,000 | 40,000 | 52,852 $0 | 8 |
Jul 01, 2021
Reduced 15.91%
|
|
Joanne L. Viney
Director |
21,028 | 0 | 21,028 $0 | 1 |
Apr 01, 2023
Added 50.0%
|
|
Alan Colowick
Director |
16,456 | 0 | 16,456 $0 | 1 |
Apr 01, 2023
Added 50.0%
|
| 46,472 | 13,224 | 12,801 $0 | 7 |
Jan 01, 2024
Added 7.73%
|
|
| 5,415 | 5,415 | 0 $0 | 3 |
Mar 11, 2024
Reduced 100.0%
|
|
| 5,000 | 5,000 | 0 $0 | 2 |
Mar 11, 2024
Reduced 100.0%
|
|
| 83,404 | 22,665 | 0 $0 | 6 |
Mar 11, 2024
Reduced 100.0%
|
|
|
Julia Marie Eastland
President and CEO |
259,750 | 269,381 | 0 $0 | 4 |
Mar 11, 2024
Reduced 100.0%
|
| 46,472 | 13,224 | 0 $0 | 7 |
Mar 11, 2024
Reduced 100.0%
|
|
| 5,000 | 5,000 | 0 $0 | 2 |
Mar 11, 2024
Reduced 100.0%
|
|
| 5,000 | 5,000 | 0 $0 | 2 |
Mar 11, 2024
Reduced 100.0%
|
|
|
Luke Nathaniel Walker
Chief Medical Officer |
135,000 | 135,000 | 0 $0 | 3 |
Mar 11, 2024
Reduced 100.0%
|
|
Frank J Lanza
Principal Fin. & Acctng Ofc. |
17,000 | 18,734 | 0 $0 | 3 |
Mar 11, 2024
Reduced 100.0%
|
| 1,372,000 | 1,473,386 | 0 $0 | 2 |
Mar 11, 2024
Reduced 100.0%
|